1. Home
  2. CRTO vs ACHV Comparison

CRTO vs ACHV Comparison

Compare CRTO & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

N/A

Current Price

$15.21

Market Cap

818.3M

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$7.56

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CRTO
ACHV
Founded
2005
N/A
Country
France
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
818.3M
726.5M
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
CRTO
ACHV
Price
$15.21
$7.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
★ $34.00
$13.83
AVG Volume (30 Days)
199.5K
★ 1.4M
Earning Date
05-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.95
N/A
EPS
★ 0.37
N/A
Revenue
★ $2,296,692,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.54
N/A
P/E Ratio
$42.41
★ N/A
Revenue Growth
★ 27.65
N/A
52 Week Low
$15.26
$2.62
52 Week High
$25.29
$8.64

Technical Indicators

Market Signals
Indicator
CRTO
ACHV
Relative Strength Index (RSI) 28.02 53.53
Support Level N/A $7.01
Resistance Level $19.85 $8.56
Average True Range (ATR) 0.44 0.36
MACD -0.12 -0.01
Stochastic Oscillator 7.91 62.91

Price Performance

Historical Comparison
CRTO
ACHV

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: